PER 2.44% 8.4¢ percheron therapeutics limited

Sarepta FDA Hearing, page-55

  1. 3,131 Posts.
    lightbulb Created with Sketch. 507
    using Sarepta's revenue as an income guide, with just 30% of the dmd population, earning 1B USD a year, one could assume 90% would = $3B USD or $4B AUD in the USA alone. Double this for the EU and there's $8B AUD per year. That sounds crazy... but it IS happening right now.

    $8B x 20 (about current SRPT ratio) = $160B or $160 dollars a share. hmmm what could I buy with that kind of money.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.002(2.44%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.2¢ 8.4¢ 8.1¢ $27.59K 335.2K

Buyers (Bids)

No. Vol. Price($)
1 24826 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 156937 2
View Market Depth
Last trade - 16.10pm 29/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.